Lenvatinib Mesylate and Risankizumab-rzaa topical
Determining the interaction of Lenvatinib Mesylate and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Risedronate
- Lenvatinib Mesylate-Risedronate and Calcium
- Lenvatinib Mesylate-Risedronate Delayed Release
- Lenvatinib Mesylate-Risedronate Delayed-Release Tablets
- Lenvatinib Mesylate-Risedronate Sodium
- Lenvatinib Mesylate-Risedronate Tablets
- Risankizumab-rzaa topical-Lenvima
- Risankizumab-rzaa topical-Lenvima (14 MG Daily Dose)
- Risankizumab-rzaa topical-Lenvima (18 MG Daily Dose)
- Risankizumab-rzaa topical-Lenvima (20 MG Daily Dose)
- Risankizumab-rzaa topical-Lenvima (24 MG Daily Dose)
- Risankizumab-rzaa topical-Lenvima (8 MG Daily Dose)